J. Michalski

发表

Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

D. Kuban, M. Zelefsky, A. Zietman, 2003, International journal of radiation oncology, biology, physics.

Future vision for the quality assurance of oncology clinical trials

W. Curran, L. Schwartz, M. Knopp, 2013, Front. Oncol..

Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy.

David Beyer, Mack Roach, D. Beyer, 2002, International journal of radiation oncology, biology, physics.

Inter-institutional variation of implant activity for permanent prostate brachytherapy.

J. Sylvester, W. Butler, G. Merrick, 2008, Brachytherapy.

Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer

J. M. Michalski, Maria Werner-Wasik, J. D. Bradley, 2014 .

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Andrea Bezjak, Hak Choy, Jeffrey Bradley, 2010, JAMA.

NCTN Assessment on Current Applications of Radiomics in Oncology.

M. Knopp, T. Solberg, P. Xia, 2019, International journal of radiation oncology, biology, physics.

Basal cell and squamous cell skin cancers.

A. Oseroff, N. Lee, J. Grichnik, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

A. Markoe, K. Russell, H. Sandler, 2000, International journal of radiation oncology, biology, physics.

Quality of life and satisfaction with outcome among prostate-cancer survivors.

John T. Wei, D. Kuban, I. Kaplan, 2008, The New England journal of medicine.

A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer.

D. Low, J. Purdy, W. Bosch, 1998, International journal of radiation oncology, biology, physics.

Standardizing naming conventions in radiation oncology.

Sasa Mutic, Lakshmi Santanam, William Straube, 2012, International journal of radiation oncology, biology, physics.

Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors.

J Wong, D Yan, J Michalski, 1997, International journal of radiation oncology, biology, physics.

Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer.

Issam El-Naqa, Mack Roach, Charles Catton, 2007, International journal of radiation oncology, biology, physics.

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Adam P Dicker, Charles R. Thomas, I-Chow Hsu, 2018, The Lancet. Oncology.

Automatic CT simulation optimization for radiation therapy: A general strategy.

Lifeng Yu, Sasa Mutic, Hiram Gay, 2014, Medical physics.

The cumulative verification image analysis tool for offline evaluation of portal images.

J Wong, D Yan, J Michalski, 1995, International journal of radiation oncology, biology, physics.

An analysis of intratreatment and intertreatment displacements in pelvic radiotherapy using electronic portal imaging.

R K Valicenti, D A Low, J M Michalski, 1996, International journal of radiation oncology, biology, physics.

Is weekly port filming adequate for verifying patient position in modern radiation therapy?

R K Valicenti, J A Purdy, J M Michalski, 1994, International journal of radiation oncology, biology, physics.

An evaluation of two methods of anatomical alignment of radiotherapy portal images.

D Low, R K Valicenti, D Yan, 1993, International journal of radiation oncology, biology, physics.

The use of on-line image verification to estimate the variation in radiation therapy dose delivery.

D Yan, J W Wong, J M Michalski, 1993, International journal of radiation oncology, biology, physics.

Prospective clinical evaluation of an electronic portal imaging device.

J Wong, R K Valicenti, J M Michalski, 1996, International journal of radiation oncology, biology, physics.

Clinical Investigation : Thoracic Cancer No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early-Stage Peripheral Non-Small Cell Lung Cancer : An Analysis of RTOG 0236

R. Timmerman, A. Bezjak, J. Bradley, 2022 .

A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526).

D. Beyer, C. Catton, H. Sandler, 2017, International journal of radiation oncology, biology, physics.

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

A. Markoe, J. Earle, H. Sandler, 2002, International journal of radiation oncology, biology, physics.

Design of a fully integrated three-dimensional computed tomography simulator and preliminary clinical evaluation.

J A Purdy, J M Michalski, P. Grigsby, 1994, International journal of radiation oncology, biology, physics.

The Impact of MRI Training on Improvement of CT Based Post Implant Dosimetry: A Six Physician Study

W. R. Lee, M. Zelefsky, P. McLaughlin, 2005 .

Errors in radiation oncology: A study in pathways and dosimetric impact

Robert E. Drzymala, James A. Purdy, Eric E. Klein, 2005, Journal of Applied Clinical Medical Physics.

Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy.

P. Parikh, J. Michalski, L. Santanam, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Role of MRI-Guided Radiation Therapy for Palliation of Mobile Abdominal Cancers: A Report of Two Cases

S. Mutic, J. Michalski, C. Robinson, 2021, Advances in radiation oncology.

First Reported Case of Pediatric Radiation Treatment With Magnetic Resonance Image Guided Radiation Therapy

S. Mutic, J. Michalski, L. Henke, 2019, Advances in radiation oncology.

Teaching Case First Reported Case of Pediatric Radiation Treatment With Magnetic Resonance Image Guided Radiation Therapy

S. Mutic, J. Michalski, M. Perkins, 2019 .

Practical Implications of Ferromagnetic Artifacts in Low-field MRI-guided Radiotherapy

P. Parikh, J. Michalski, H. Gach, 2018, Cureus.

Spatially fractionated stereotactic body radiotherapy (Lattice SBRT) for large tumors

S. Mutic, S. Goddu, J. Michalski, 2020 .

Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis

J. Michalski, H. Gay, S. Markovina, 2017, Advances in radiation oncology.

The world's first single-room proton therapy facility: Two-year experience.

D. Hallahan, J. Bradley, S. Mutic, 2016, Practical radiation oncology.

Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival

J. Michalski, H. Gay, M. Roach, 2018, Cancer medicine.

An electronic viewbox tool for radiation therapy treatment verification

D. Low, J. Purdy, W. Bosch, 1993 .

Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.

D. Hallahan, J. Bradley, J. Michalski, 2018, International journal of radiation oncology, biology, physics.

National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.

R. Mohan, B. Vikram, H. Kooy, 2018, International journal of radiation oncology, biology, physics.

Basal cell and squamous cell skin cancers. Clinical practice guidelines in oncology.

T. Olencki, N. Lee, R. Cheney, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

An evaluation of departmental radiation oncology incident reports: anticipating a national reporting system.

Sasa Mutic, Hiram Gay, Lakshmi Santanam, 2013, International journal of radiation oncology, biology, physics.

Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.

M. Stevens, J. Michalski, A. Ferrari, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Acquisition and Management of Data for Translational Science in Oncology

M. Knopp, M. Rosen, F. Prior, 2019, Translational Research in Cancer.

Distance to Radiation Facility and Treatment Choice in Early-Stage Breast Cancer.

J. Michalski, S. Acharya, S. Perkins, 2016, International journal of radiation oncology, biology, physics.

Review: Brain Metastases in Bladder Cancer

V. Arora, J. Michalski, J. Picus, 2020 .

Introduction: Locally advanced prostate cancer

J. Michalski, 2003 .

Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.

J. Sylvester, D. Beyer, T. DeWeese, 2015, International journal of radiation oncology, biology, physics.

Physician resource utilization in radiation oncology: a model based on management of carcinoma of the prostate.

J. Michalski, C. Perez, N. Dopuch, 1998, International journal of radiation oncology, biology, physics.

Clinical trials and radiation oncology technologies.

J. Purdy, W. Bosch, J. Michalski, 2009, Oncology.

ACR–ASTRO Practice Parameter for Communication

H. Shih, J. Michalski, Derek W. Brown, 2020, American journal of clinical oncology.

Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma

J. Michalski, M. Bussière, N. Tarbell, 2013, Cancer.

Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis.

A. Kishan, R. Mehra, H. Sandler, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose escalation in locally advanced carcinoma of the prostate.

J. Michalski, A. Blanco, 2003, Seminars in radiation oncology.

Cell-free DNA alterations in the AR enhancer and locus predict resistance to AR-directed therapy in patients with metastatic prostate cancer.

Jingqin Luo, C. Maher, A. Chaudhuri, 2020, JCO precision oncology.

Long term outcome with post-operative radiation therapy for spinal canal ependymoma

S. Wahab, J. Michalski, J. Simpson, 2007, Journal of Neuro-Oncology.

Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with Inoperable NSCLC

J. Fowler, R. Govindan, H. Choy, 2005 .

NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer

D. Low, H. Sandler, M. Amin, 2016 .

On-line image verification in radiation therapy: an early USA experience.

P. Grigsby, J. Wong, J. Michalski, 1993, Medical progress through technology.

An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method: Executive summary

D. Beyer, J. Michalski, A. Mundt, 2015, Advances in radiation oncology.

Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Jennifer L. Hadley, T. Merchant, P. Northcott, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Imaging and Neuro-Oncology Clinical Trials of the National Clinical Trials Network (NCTN)

M. Knopp, M. Rosen, F. Prior, 2019, Neuroimaging - Neurobiology, Multimodal and Network Applications.

RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: implications for improving patient recruitment.

C. Gwede, B. Prestidge, J. Michalski, 2010, Contemporary clinical trials.

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

J. Michalski, J. Luh, S. Finkelstein, 2018, Annals of Internal Medicine.

Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief report.

J. Purdy, W. Bosch, J. Michalski, 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.

M. Kattan, A. Kibel, J. Ciezki, 2013, European urology.

VA-Radiation Oncology Quality Surveillance Program.

L. Potters, I. Chetty, J. DeMarco, 2020, International journal of radiation oncology, biology, physics.

Do not count out external-beam radiation therapy for high-risk prostate cancer.

H. Sandler, J. Michalski, D. Hamstra, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.

S. Goldenberg, M. Roach, B. Davis, 2013, The Journal of urology.

Impact of Facility Radiation Patient Volume on Overall Survival in Patients with Muscle Invasive Bladder Cancer Undergoing Trimodality Bladder Preservation Therapy

J. Michalski, H. Gay, B. Baumann, 2019 .

Adherence of United States Insurance Payer Policies to American Society of Radiation Oncology (ASTRO) Stereotactic Radiosurgery (SRS) Model Policy.

J. Michalski, C. Tsien, C. Robinson, 2020, Practical radiation oncology.

Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.

James R. Anderson, E. Gehan, J. Meza, 2002, Medical and pediatric oncology.

Clinical assessment of outcome of prostate cancer (TCP, NTCP).

J. Michalski, C. Perez, D. Mansur, 2005, Rays.

Low incidence of new biochemical hypogonadism after intensity modulated radiation therapy for prostate cancer.

J. Michalski, H. Gay, T. DeWees, 2014, Practical radiation oncology.

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Post-Operative Prostate Cancer.

D. Dearnaley, M. Harisinghani, H. Sandler, 2020, International journal of radiation oncology, biology, physics.

Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall.

W. Bosch, J. Michalski, H. Gay, 2017, Practical radiation oncology.

Fit of a Generalized Lyman Normal-Tissue Complication Probability (NTCP) Model to Grade ≥ 2 Late Rectal Toxicity Data From Patients Treated on Protocol RTOG 94-06

Lei Dong, R. Mohan, D. Kuban, 2007 .

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.

J. Fowler, R. Govindan, H. Choy, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.

W. Sause, J. Michalski, Srinivasan Vijayakumar, 1998, International journal of radiation oncology, biology, physics.

Radiation exposure to family and household members after prostate brachytherapy.

J. Eichling, S. Mutic, J. Michalski, 2003, International journal of radiation oncology, biology, physics.

Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial.

C. Parker, J. Michalski, S. Nilsson, 2016, European urology.

Postoperative radiation therapy for grade II and III intracranial ependymoma.

P. Grigsby, S. Wahab, J. Michalski, 2005, International journal of radiation oncology, biology, physics.

Management of primary skin cancer during a pandemic: Multidisciplinary recommendations

Christopher J. Miller, L. Wilson, N. Lee, 2020, Cancer.

Basal cell and squamous cell skin cancers.

T. Olencki, N. Lee, R. Cheney, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial

D. Low, H. Sandler, G. Swanson, 2019, JAMA oncology.

Isolated CNS relapse following stem cell transplantation for juvenile myelomonocytic leukemia.

J. Michalski, W. Grossman, David B. Wilson, 2003, Journal of pediatric hematology/oncology.

Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation.

E. Trulock, J. Michalski, J. Lynch, 1998, International journal of radiation oncology, biology, physics.

Preliminary patient‐reported outcomes analysis of 3‐dimensional radiation therapy versus intensity‐modulated radiation therapy on the high‐dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial

J. Galvin, H. Sandler, M. Amin, 2015, Cancer.

Update of toxicity following 3D radiation therapy for prostate cancer on RTOG 9406

A. Markoe, H. Sandler, J. Purdy, 2000 .

A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117.

J. Fowler, R. Govindan, H. Choy, 2010, International journal of radiation oncology, biology, physics.

In regard to Beyer, Nath, and Butler et al. IJROBP 2000;47:273-275.

J. Williamson, J. Michalski, 2001, International journal of radiation oncology, biology, physics.

A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.

A. Kishan, M. Cooperberg, P. Carroll, 2020, European urology.

Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience

J. Michalski, B. V. Van Tine, J. Olsen, 2017, Radiation Oncology.

Rebuttal to Drs. Hussein and Cooperberg.

J. Michalski, S. Markovina, 2015, Brachytherapy.

Point/Counterpoint Rebuttal to Drs. Hussein and Cooperberg

J. Michalski, S. Markovina, 2015 .

Dermatofibrosarcoma ProtuberansPractice Guidelines in Oncology

T. Olencki, R. Cheney, J. Michalski, 2012 .

Dermatofibrosarcoma protuberans.

A. Oseroff, N. Lee, J. Grichnik, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Dermatofibrosarcoma protuberans. Clinical practice guidelines in oncology.

T. Olencki, R. Cheney, J. Michalski, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

The Importance of Imaging in Radiation Oncology for National Clinical Trials Network Protocols.

P. Okunieff, L. Schwartz, M. Knopp, 2018, International journal of radiation oncology, biology, physics.

An integrated image/clinical database for outcome studies in 3D conformal radiation therapy*

J. Purdy, W. Bosch, J. Michalski, 1998 .

A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life.

John T. Wei, H. Sandler, R. Dess, 2018, Practical Radiation Oncology.

Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.

J. Michalski, S. Kry, E. Zubizarreta, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521).

R. Hannan, J. Purdy, M. Amin, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of COG ACNS0331: A Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) with Chemotherapy in Average-Risk Medulloblastoma: A Report from the Children's Oncology Group

T. Merchant, R. Timmerman, I. Pollack, 2016 .

Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol.

G. Ibbott, J. Michalski, M. Gillin, 2006, Brachytherapy.

Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy

J. Efstathiou, V. Arora, J. Michalski, 2020, Clinical Genitourinary Cancer.

Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial

A. Zietman, H. Sandler, R. Dess, 2019, International Journal of Radiation Oncology*Biology*Physics.

Toxicity following 3D radiation therapy for prostate cancer on RTOG 9406 dose level IV

A. Markoe, H. Sandler, J. Purdy, 2002 .

MR Image-Guided Adaptive Radiotherapy : First Clinical Applications

P. Parikh, S. Mutic, J. Michalski, 2015 .

Radiotherapy plus chemotherapy for head and neck cancer.

J. Michalski, B. Emami, 1993, The New England journal of medicine.

Larry Emanuel Kun, March 10, 1946-May 27, 2018.

T. Merchant, H. Choy, S. Donaldson, 2019, International journal of radiation oncology, biology, physics.

Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability.

J. Michalski, C. Robinson, B. Fischer-Valuck, 2019, Practical radiation oncology.

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate

J. Michalski, H. Gay, B. Baumann, 2019, Front. Oncol..

Glioblastoma in children: a single-institution experience.

M. Smyth, I. El Naqa, J. Michalski, 2011, International journal of radiation oncology, biology, physics.

Long-term outcome in children treated for craniopharyngioma with and without radiotherapy.

I. El Naqa, J. Michalski, T. Park, 2008, Journal of neurosurgery. Pediatrics.

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database

G. Andriole, V. Arora, J. Michalski, 2018, Clinical and translational radiation oncology.

Primary Endpoint Analysis of a Randomized Phase III Trial of Hypofractionated vs. Conventional Post-Prostatectomy Radiotherapy: NRG Oncology GU003.

L. Potters, R. Hannan, H. Sandler, 2021, International journal of radiation oncology, biology, physics.

Initial Report of NRG Oncology/RTOG 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma

D. Beyer, C. Catton, H. Sandler, 2016 .

Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP).

I. Kaplan, D. Beyer, H. Sandler, 2016 .

The biochemical and clinical significance of the post-treatment PSA bounce for prostate cancer patients treated with external beam radiation therapy alone: A multi-institutional pooled analysis

D. Kuban, M. Zelefsky, A. Zietman, 2004 .

Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial

D. Low, H. Sandler, É. Vigneault, 2018, International Journal of Radiation Oncology*Biology*Physics.

An analysis of intratreatment and intertreatment variations in pelvic patient positioning using electronic portal imaging

R. Valicenti, W. Bosch, J. Michalski, 1994 .

Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.

Sasa Mutic, Olga Green, Rojano Kashani, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Bladder Cancer, Version 2.2016 Featured Updates to the NCCN Guidelines

Geoffrey E. Wile, A. Kibel, S. Boorjian, 2016 .

Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018.

R. Timmerman, T. DeWeese, S. Donaldson, 2019, International journal of radiation oncology, biology, physics.

Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer

J. Galvin, H. Choy, R. Timmerman, 2018, JAMA oncology.

Method to plan, administer, and verify supine craniospinal irradiation

J. Michalski, E. Klein, R. Gerber, 2002, Journal of applied clinical medical physics.

Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.

Issam El Naqa, Mark K Buyyounouski, Richard K Valicenti, 2010, International journal of radiation oncology, biology, physics.

RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.

C. Ménard, M. Ritter, J. Michalski, 2009, International journal of radiation oncology, biology, physics.

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Richard K Valicenti, Jeff M Michalski, Michael W Kattan, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MP72-01 IMPROVEMENTS IN FREEDOM FROM PROGRESSION WITH SHORT TERM ANDROGEN DEPRIVATION THERAPY AND PELVIC LYMPH NODE TREATMENT ADDED TO PROSTATE BED SALVAGE RADIOTHERAPY: THE NRG ONCOLOGY/RTOG 0534 SPPORT TRIAL

D. Low, H. Sandler, J. Michalski, 2019, Journal of Urology.

Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial

H. Sandler, M. Lock, J. Purdy, 2018, JAMA oncology.

Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.

Issam El Naqa, David Gaffney, Christopher Willett, 2012, International journal of radiation oncology, biology, physics.

Estimation of α/β for late rectal toxicity based on RTOG 94-06.

Lei Dong, R. Mohan, J. Purdy, 2011, International journal of radiation oncology, biology, physics.

Errors in radiation oncology: A study in pathways and dosimetric impact

Robert E. Drzymala, James A. Purdy, Eric E. Klein, 2005, Journal of applied clinical medical physics.

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.

Lei Dong, R. Mohan, D. Kuban, 2010, International journal of radiation oncology, biology, physics.

Dermatofibrosarcoma protuberans.

T. Olencki, R. Cheney, J. Michalski, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.

J. Meza, S. Donaldson, D. Rodeberg, 2012, International journal of radiation oncology, biology, physics.

Penile cancer: Clinical Practice Guidelines in Oncology.

Geoffrey E. Wile, J. Richie, D. Kuban, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Quality of Intensity Modulated Radiation Therapy Treatment Plans Using a ⁶⁰Co Magnetic Resonance Image Guidance Radiation Therapy System.

Sasa Mutic, Deshan Yang, Kari Tanderup, 2015, International journal of radiation oncology, biology, physics.

Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure.

P. Grigsby, J. Michalski, J. Simpson, 1990, Radiology.

Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II–IV, 1978–1997: Report from the Children's Oncology Group

F. Ullrich, S. Donaldson, J. Michalski, 2008, Pediatric blood & cancer.

Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial.

David T. W. Jones, J. Olson, T. Zhou, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Counterpoint: Unfair comparisons lead to unwarranted conclusions-Can treatment modalities for localized prostate cancer truly be compared without bias?

J. Michalski, S. Markovina, 2015, Brachytherapy.

Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.

B. Fisher, J. Michalski, Yuhchyau Chen, 2017, International journal of radiation oncology, biology, physics.

Predictors of Radiotherapy-related GI Toxicity from Anal Cancer DP-IMRT: Secondary Analysis of NRG Oncology RTOG 0529

B. Fisher, J. Michalski, Chang, 2017 .

Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.

J. Fleshman, J. Michalski, M. Lockett, 1995, International journal of radiation oncology, biology, physics.

Radiation Therapy as Definitive Local Treatment in Patients with Limited-Stage Small Cell Carcinoma of the Bladder: Does total dose matter?

J. Michalski, H. Gay, Y. Rao, 2018, Bladder cancer.

Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.

J. Michalski, H. Gay, Y. Rao, 2017, European urology focus.

Treatment of Non‐Metastatic Muscle‐Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

Yair Lotan, Roger Chou, Todd M Morgan, 2017, The Journal of urology.

NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.

Geoffrey E. Wile, A. Kibel, S. Boorjian, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.

W. R. Lee, A. Kishan, A. Zietman, 2020, JAMA oncology.

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.

R. Hannan, H. Sandler, J. Purdy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.

D. Kuban, M. Zelefsky, A. Zietman, 2005, The Journal of urology.

Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint.

J. Michalski, C. Perez, M. Lockett, 2001, International journal of radiation oncology, biology, physics.

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

W. Curran, H. Choy, J. Sloan, 2016, JAMA oncology.

Bladder Cancer , Version 5 . 2017 Clinical Practice Guidelines in Oncology

Geoffrey E. Wile, S. Boorjian, N. Agarwal, 2017 .

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.

Shree Agrawal, Daniel A Hamstra, Jeff M Michalski, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.

M. Kattan, A. Zietman, M. Anscher, 2016, International journal of radiation oncology, biology, physics.

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

Christopher U. Jones, K. Pienta, D. Grignon, 2015, International journal of radiation oncology, biology, physics.

Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analy

K. Pienta, H. Sandler, J. Michalski, 2009, International journal of radiation oncology, biology, physics.

Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.

M. Kattan, J. Deasy, A. Kibel, 2012, The Journal of urology.

Radiation therapy in the management of locally advanced prostate cancer

J. Michalski, 2006 .

Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

S. Boorjian, N. Agarwal, Sam S. Chang, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

11: Impact of Prostate Cancer Patient Treatment Outcome on HRQOL and Satisfaction with Cancer Care among Their Spouses

John T. Wei, Xihong Lin, R. Dunn, 2007 .

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Anthony Patterson, Mark K Buyyounouski, Khurshid A Guru, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Bladder cancer.

Geoffrey E. Wile, J. Richie, D. Kuban, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

D. Low, H. Sandler, M. Amin, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of Radiation Therapy Oncology Group 94-06.

H. Sandler, R. Valicenti, J. Michalski, 2011, International journal of radiation oncology, biology, physics.

Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database.

W. Curran, M. Mehta, J. Michalski, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation therapy for increasing prostate-specific antigen levels after radical prostatectomy.

G. Andriole, J. Michalski, C. Perez, 2003, Clinical prostate cancer.

Three-dimensional conformal therapy versus standard radiation therapy in localized carcinoma of prostate: an update.

J. Michalski, C. Perez, M. Lockett, 2002, Clinical prostate cancer.

Childhood and adolescent thyroid carcinoma

P. Grigsby, J. Michalski, G. Doherty, 2002, Cancer.

Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison.

James A. Purdy, Jeff M. Michalski, Todd H. Wasserman, 2000, International journal of radiation oncology, biology, physics.

Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features

A. Niemierko, A. Zietman, M. Anscher, 2018, JAMA oncology.

Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.

A. Zietman, M. Anscher, J. Hearn, 2017, European urology.

Adjuvant radiation therapy, androgen deprivation, and docetaxel for high‐risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621

K. Badiozamani, D. Beyer, H. Sandler, 2017, Cancer.

Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma

J. Michalski, B. Baumann, P. Oppelt, 2019, Front. Oncol..

The Importance of Temporary Telehealth Parity Laws to Improve Public Health During COVID-19 and Future Pandemics

J. Michalski, B. Baumann, Kelly M MacArthur, 2020, International Journal of Radiation Oncology*Biology*Physics.

Bladder cancer, version 3.2020

S. Boorjian, N. Agarwal, Sam S. Chang, 2020 .

Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).

Steve B. Jiang, R. Xu, W. Bosch, 2017, International journal of radiation oncology, biology, physics.

Tumor and target delineation: current research and future challenges.

G T Chen, J Rosenman, M Goitein, 1995, International journal of radiation oncology, biology, physics.

American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology

Ying Xiao, Todd McNutt, Lawrence B. Marks, 2017, International journal of radiation oncology, biology, physics.

Molecular (functional) imaging for radiotherapy applications: an RTOG symposium.

Jeffrey D Bradley, Janet F Eary, S M Larson, 2003, International journal of radiation oncology, biology, physics.

Chapter 53 – Prostate Cancer

L. Potters, T. Pisansky, J. Michalski, 2016 .

MB-109PRELIMINARY RESULTS OF COG ACNS0331: A PHASE III TRIAL OF INVOLVED FIELD RADIOTHERAPY (IFRT) AND LOW DOSE CRANIOSPINAL IRRADIATION (LD-CSI) WITH CHEMOTHERAPY IN AVERAGE RISK MEDULLOBLASTOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP

T. Merchant, I. Pollack, P. Burger, 2016 .

Intensity-modulated radiotherapy for prostate cancer

J. Michalski, Y. Rao, B. Fischer-Valuck, 2018, Translational andrology and urology.

Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.

James A. Purdy, Jeff M. Michalski, Walter J. Curran, 2009, International journal of radiation oncology, biology, physics.

Oligodendrogliomas in children

M. Smyth, G. Linette, R. Grubb, 2011, Journal of Neuro-Oncology.

Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry.

L. Potters, K. Hoffman, A. Zietman, 2013, Journal of oncology practice.

Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.

D. Kuban, M. Zelefsky, A. Zietman, 2003, International journal of radiation oncology, biology, physics.

Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma

J. Michalski, B. V. Van Tine, P. Oppelt, 2021, Clinical and translational radiation oncology.

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Anthony Patterson, Mark K Buyyounouski, Khurshid A Guru, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Predicting dose-volume histograms for organs-at-risk in IMRT planning.

Sasa Mutic, Wade L Thorstad, Jeff M Michalski, 2012, Medical physics.

Long-Term Benefits of Dose-Escalation in Localized Prostate Cancer.

D. Spratt, J. Michalski, 2019, International journal of radiation oncology, biology, physics.

Radiation Therapy for Carcinoma of the Renal Pelvis and Ureters

J. Michalski, L. Brady, J. E. Lahaniatis, 1999 .

Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial

Parag J. Parikh, Sasa Mutic, Rojano Kashani, 2018, Advances in radiation oncology.

Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.

J. Michalski, B. Movsas, C. Scott, 2000, International journal of radiation oncology, biology, physics.

Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.

J. Meza, S. Donaldson, J. Michalski, 2004, International journal of radiation oncology, biology, physics.

Current calibration, treatment, and treatment planning techniques among institutions participating in the Children's Oncology Group.

Fran Laurie, David Followill, T J FitzGerald, 2003, International journal of radiation oncology, biology, physics.

The Efficacy of Radiation Therapy in the Management of Grade I Astrocytomas

J. Michalski, A. Perry, J. Simpson, 2005, Journal of Neuro-Oncology.

Clinical Outcomes and Prognostic Features of Angiosarcoma: Significance of Prior Radiation Therapy.

J. Michalski, B. V. Van Tine, M. Spraker, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.

C. N. Coleman, M. Knopp, B. Vikram, 2016, International journal of radiation oncology, biology, physics.

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

Christopher U. Jones, J. Torres-Roca, H. Sandler, 2015, International journal of radiation oncology, biology, physics.

A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children’s oncology group

R. McLendon, P. Burger, J. Michalski, 2006, Journal of Neuro-Oncology.

Early toxicity predicts long-term survival in high-grade glioma

W. Curran, M. Mehta, W. Yung, 2011, British Journal of Cancer.

Age as an independent prognostic factor in patients with glioblastoma: a radiation therapy oncology group and American College of Surgeons National Cancer Data Base comparison

Luis Souhami, Arnab Chakravarti, Kimberly Porter, 2011, Journal of Neuro-Oncology.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Christopher U. Jones, H. Sandler, A. Raben, 2017, Advances in radiation oncology.

Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children

J. Michalski, M. Bussière, N. Tarbell, 2015, Cancer.

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients

Christopher U. Jones, A. Markoe, W. Yung, 2018, Journal of Neuro-Oncology.

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

D. Kuban, M. Zelefsky, A. Zietman, 2003, International journal of radiation oncology, biology, physics.

Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.

D. Kuban, I. Kaplan, O. Garin, 2016, International journal of radiation oncology, biology, physics.

Cost benefit of emerging technology in localized carcinoma of the prostate.

J. Michalski, C. Perez, M. Lockett, 1997, International journal of radiation oncology, biology, physics.

Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.

J. Michalski, C. Perez, M. Lockett, 1996, International journal of radiation oncology, biology, physics.

Clinical Investigation : The Profession A Research Agenda for Radiation Oncology : Results of the Radiation Oncology Institute ’ s Comprehensive Research Needs Assessment

Quynh-Thu Le, Benjamin Movsas, Joseph O Deasy, 2012 .

W. Curran, Meihua Wang, M. Mehta, 2009, Journal of Neuro-Oncology.

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer

G. Andriole, T. Guzzo, V. Arora, 2019, Cancer medicine.

Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.

Tianyu Zhao, Sasa Mutic, Deshan Yang, 2016, International journal of radiation oncology, biology, physics.

Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience.

John T. Wei, D. Kuban, I. Kaplan, 2013, International journal of radiation oncology, biology, physics.

Report dose-to-medium in clinical trials where available; a consensus from the global Harmonisation group to maximize consistency.

D. Followill, J. Michalski, S. Kry, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prospective study evaluating the use of IV contrast on IMRT treatment planning for lung cancer.

D. Low, J. Bradley, S. Mutic, 2014, Medical physics.

Innovations in Three-Dimensional Treatment Planning and Quality Assurance

J A Purdy, J M Michalski, J. Purdy, 1998, Tumori.

Clinical evaluation of a commercial orthopedic metal artifact reduction tool for CT simulations in radiation therapy.

Sasa Mutic, Daniel Low, Camille Noel, 2012, Medical physics.

Head and neck quality assurance 2014

M. Knopp, J. Galvin, M. Rosen, 2016 .

MR-Guided Adaptive Radiotherapy for Bladder Cancer

A. Bertelsen, J. Michalski, A. Hijab, 2021, Frontiers in Oncology.

2222 Variation in the Definition of Clinical Target Volumes for Postoperative Conformal Radiation Therapy of

C. Catton, H. Sandler, M. Ritter, 2007 .

Tools for consensus analysis of experts' contours for radiotherapy structure definitions.

Issam El Naqa, X Allen Li, Rawan Allozi, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.

J. Meza, S. Donaldson, J. Michalski, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.

Hiram Gay, Anupama Chundury, Rodney Ellis, 2017, International journal of radiation oncology, biology, physics.

In Regard to Habl et al.

B. Davis, T. Pisansky, J. Michalski, 2016, International journal of radiation oncology, biology, physics.

Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.

Christopher U. Jones, R. Hannan, H. Sandler, 2020 .

The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.

D. Kuban, M. Zelefsky, A. Zietman, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

A. Markoe, H. Sandler, K. Bae, 2010, International journal of radiation oncology, biology, physics.

A randomized trial of 79.2Gy versus 70.2Gy radiation therapy (RT) for localized prostate cancer.

H. Sandler, M. Lock, J. Purdy, 2015 .

Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.

J. Blasko, J. Sylvester, P. Grimm, 2007, Brachytherapy.

Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.

Sasa Mutic, Adam P Dicker, Ying Xiao, 2015, International journal of radiation oncology, biology, physics.

Definitions of biochemical failure that best predict clinical failure in prostate cancer patients treated with external beam radiation alone- a multi-institutional pooled analysis

D. Kuban, M. Zelefsky, A. Zietman, 2003 .

Biochemical and clinical significance of the posttreatment prostate‐specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone

D. Kuban, M. Zelefsky, A. Zietman, 2006, Cancer.

Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.

Jeff M Michalski, Mack Roach, James A Purdy, 2005, International journal of radiation oncology, biology, physics.

Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.

Richard K Valicenti, Jeff M Michalski, Mack Roach, 2004, International journal of radiation oncology, biology, physics.

Hematologic Safety of Radium‐223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial

C. Parker, J. Michalski, S. Nilsson, 2017, Clinical genitourinary cancer.

Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.

Tianyu Zhao, Sasa Mutic, Olga Green, 2016, International journal of radiation oncology, biology, physics.

Positron tomographic assessment of androgen receptors in prostatic carcinoma

C. Dence, M. Welch, J. Katzenellenbogen, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.

J. Galvin, H. Sandler, W. Bosch, 2013, International journal of radiation oncology, biology, physics.

The CT-simulation 3-D treatment planning process.

J A Purdy, J M Michalski, J. Purdy, 1996, Frontiers of radiation therapy and oncology.

Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.

J. Galvin, R. Timmerman, L. Papiez, 2007, International journal of radiation oncology, biology, physics.

A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617.

W. Curran, K. Forster, H. Choy, 2013 .

Bone Health and Bone-Targeted Therapies for Prostate Cancer: American Society of Clinical Oncology Endorsement Summary of a Cancer Care Ontario Guideline.

J. Michalski, R. B. Rumble, P. Saylor, 2020, JCO oncology practice.

Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline.

J. Eastham, A. Finelli, J. Michalski, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

18F-Fluciclovine positron emission tomography in men with biochemical recurrence of prostate cancer after radical prostatectomy and planning to undergo salvage radiotherapy: Results from LOCATE.

J. Tward, J. Michalski, N. Vapiwala, 2020, Practical radiation oncology.

Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment

John T. Wei, I. Kaplan, A. Kibel, 2017, The Journal of urology.

Prediction of erectile function following treatment for prostate cancer.

John T. Wei, M. Cooperberg, P. Carroll, 2011, JAMA.

Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience.

S Mutic, P Parikh, V Rodriguez, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy.

J. Hearn, D. Spratt, J. Efstathiou, 2021, European urology oncology.

Adding short-term androgen deprivation therapy to RT in men with localized prostate cancer: long-term update of the NRG/RTOG 9408 randomized clinical trial.

Christopher U. Jones, A. Zietman, H. Sandler, 2021, International journal of radiation oncology, biology, physics.

Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer

Hak Choy, Geoffrey Ibbott, William Straube, 2006, Acta oncologica.

The ABR OLA Part 3 Maintenance of Certification Instrument: Rationale and Summary of Six-Months Experience.

A. Ng, S. Segal, J. Michalski, 2020, Practical Radiation Oncology.

11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.

Nobuyuki Oyama, Jeff M Michalski, Michael J Welch, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.

R. Chou, Y. Lotan, Sam S. Chang, 2017, Journal of oncology practice.

Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406.

A. Markoe, H. Sandler, J. Purdy, 2004, International journal of radiation oncology, biology, physics.

Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.

D. Kuban, M. Zelefsky, A. Zietman, 2004, International journal of radiation oncology, biology, physics.

Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT

J. Michalski, S. Strope, R. Grubb, 2014, World Journal of Urology.

Secondary malignancy among seminoma patients treated with adjuvant radiation therapy.

J. Michalski, C. Perez, C. Chao, 1995, International journal of radiation oncology, biology, physics.

Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy.

John T. Wei, T. Skolarus, D. Kuban, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.

D. Kuban, M. Zelefsky, A. Zietman, 2004, International journal of radiation oncology, biology, physics.

Early results from Children's Oncology Group (COG) ARST0431: Intensive multidrug therapy for patients with metastatic rhabdomyosarcoma (RMS).

James R. Anderson, J. Michalski, D. Hawkins, 2010 .

Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study.

John T. Wei, D. Kuban, R. Dunn, 2013, Urology.

Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.

Nan Li, David Followill, William Straube, 2017, International journal of radiation oncology, biology, physics.

Quality improvements in radiation oncology clinical trials

F. Prior, Ashish Sharma, J. Michalski, 2023, Frontiers in Oncology.

Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.

A. Markoe, H. Sandler, J. Purdy, 2003, International journal of radiation oncology, biology, physics.

Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406.

A. Markoe, H. Sandler, J. Purdy, 2002, Seminars in radiation oncology.

Treatment Results with External Beam Radiation Therapy for Localized Carcinoma of the Prostate (Stages T1b, T2, and T3)

J. Michalski, C. Perez, M. Lockett, 1996 .

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.

I. Kaplan, D. Beyer, H. Sandler, 2018, International journal of radiation oncology, biology, physics.

Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.

R. Mohan, J. Purdy, W. Bosch, 2012, International journal of radiation oncology, biology, physics.

Overview of Image-Guided Localization Modalities

P. Parikh, J. Michalski, 2008 .

Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.

Walter J Curran, Richard Simon, J Jack Lee, 2012, International journal of radiation oncology, biology, physics.

Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database

J. Michalski, H. Gay, Y. Rao, 2018, The Journal of urology.

Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups.

D. Kuban, M. Zelefsky, A. Zietman, 2006, International Journal of Radiation Oncology, Biology, Physics.

Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?

D. Kuban, M. Zelefsky, A. Zietman, 2003, International journal of radiation oncology, biology, physics.

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer

J. Michalski, H. Gay, B. Baumann, 2019, Journal of contemporary brachytherapy.

A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.

D. Kuban, C. Roehrborn, P. Scardino, 2005, Urology.

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy

D. Hallahan, J. Metz, J. Michalski, 2020, British Journal of Cancer.

Long-term results of NRG Oncology/RTOG 0321 a phase II trial of combined high dose rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate.

I. Hsu, G. Gustafson, H. Sandler, 2019, International journal of radiation oncology, biology, physics.

Detecting a Survival Benefit to Dose Escalation-Reply.

J. Michalski, J. Dignam, K. Winter, 2019, JAMA oncology.

Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines.

Oliver Sartor, Richard K Valicenti, Mack Roach, 2013, International journal of radiation oncology, biology, physics.

Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.

J. Purdy, M. Roach, W. Bosch, 2004, International journal of radiation oncology, biology, physics.

External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.

John T. Wei, D. Kuban, R. Dunn, 2017, International journal of radiation oncology, biology, physics.

Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas.

J. Purdy, J. Michalski, W. Harms, 1995, International journal of radiation oncology, biology, physics.

Impact of Elapsed Treatment Time on Outcome of External‐Beam Radiation Therapy for Localized Carcinoma of the Prostate

J. Michalski, C. Perez, M. Lockett, 2004, Cancer journal.

RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?

H. Sandler, J. Purdy, R. Valicenti, 2003, International journal of radiation oncology, biology, physics.

Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group.

James R. Anderson, S. Donaldson, D. Rodeberg, 2011, International journal of radiation oncology, biology, physics.

INFLUENCE OF NON-COMPLIANCE WITH RADIATION THERAPY PROTOCOL GUIDELINES AND OPERATIVE BED RECURRENCES FOR CHILDREN WITH RHABDOMYOSARCOMA AND MICROSCOPIC RESIDUAL DISEASE: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP

S. Donaldson, D. Rodeberg, J. Michalski, 2015 .

Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking.

Lakshmi Santanam, Parag J Parikh, Jeff M Michalski, 2009, International journal of radiation oncology, biology, physics.

Toxicity Analysis of RTOG 0236 Using Stereotactic Body Radiation Therapy to Treat Medically Inoperable Early Stage Lung Cancer Patients

J. Galvin, H. Choy, R. Timmerman, 2007 .

Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126)

H. Sandler, M. Lock, J. Purdy, 2014 .

285 OVERALL AND CANCER SPECIFIC SURVIVAL FOLLOWING DEFINITIVE THERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER IN THE PROSTATE-SPECIFIC ANTIGEN ERA

M. Kattan, J. Deasy, A. Kibel, 2010 .

Phase III study of pembrolizumab (pembro) plus chemoradiotherapy (CRT) versus CRT alone for patients (pts) with muscle-invasive bladder cancer (MIBC): KEYNOTE-992.

S. Shariat, A. Balar, N. James, 2020 .

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities

I. Hsu, E. Horwitz, D. D'Souza, 2018, Advances in radiation oncology.

Optimal Equations for Describing the Relationship Between Prostate Volume, Number of Sources, and Total Activity in Permanent Prostate Brachytherapy

J. Sylvester, W. Butler, G. Merrick, 2009, American journal of clinical oncology.

Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy.

D. Kuban, M. Zelefsky, C. Catton, 2005, International journal of radiation oncology, biology, physics.

Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure.

D. Kuban, M. Zelefsky, A. Zietman, 2006, Urology.

Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial.

J. Sylvester, D. Beyer, T. DeWeese, 2018, Practical radiation oncology.

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

I. Kaplan, D. Beyer, H. Sandler, 2016 .

A phase III protocol of androgen suppression (AS) and radiation therapy (RT) versus AS and RT followed by chemotherapy with paclitaxel, estramustine, and etoposide (TEE) for localized, high-risk, prostate cancer, RTOG 9902.

H. Sandler, J. Michalski, S. Rosenthal, 2010 .

Continued Benefit to Rectal Separation for Prostate RT: Final Results of a Phase III Trial

J. Sylvester, D. Beyer, T. DeWeese, 2016 .

No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236

R. Timmerman, A. Bezjak, J. Bradley, 2012 .

P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC

J. Fowler, R. Govindan, H. Choy, 2005 .

Adaptive radiation therapy for postprostatectomy patients using real-time electromagnetic target motion tracking during external beam radiation therapy.

Mingyao Zhu, Shyam Bharat, Parag J Parikh, 2013, International journal of radiation oncology, biology, physics.

ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.

P. Carroll, G. Merrick, D. Beyer, 2009, International journal of radiation oncology, biology, physics.

Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.

R. Mohan, J. Purdy, W. Bosch, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preliminary Analysis of 3D-CRT vs. IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial: Toxicity Report

J. Galvin, H. Sandler, J. Michalski, 2011 .

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors

S. Mutic, S. Goddu, J. Michalski, 2021, Advances in radiation oncology.

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

H. Sandler, M. Regan, M. Sanda, 2014, Cancer.

Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.

Jennifer L. Hadley, J. Olson, K. Walsh, 2021, JAMA oncology.

Clinical implementation of dose-volume histogram predictions for organs-at-risk in IMRT planning

Sasa Mutic, Kevin L. Moore, L. Appenzoller, 2014 .

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.

J. Deasy, D. Low, H. Sandler, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Electronic View Box: a software tool for radiation therapy treatment verification.

D A Low, J A Purdy, W B Harms, 1995, International journal of radiation oncology, biology, physics.

American brachytherapy society recommendations for clinical implementation of nist-1999 standards for palladium-103 brachytherapy. Authors' reply

J. Blasko, B. Vikram, W. Butler, 2001 .

Satisfaction with information used to choose prostate cancer treatment.

John T. Wei, R. Dunn, E. Klein, 2014, The Journal of urology.

Event (error and near-miss) reporting and learning system for process improvement in radiation oncology.

Sasa Mutic, Daniel A Low, Bin Wu, 2010, Medical physics.

An Adaptive Low-Rank Modeling-Based Active Learning Method for Medical Image Annotation

Chunfeng Lian, Sasa Mutic, Jian Wu, 2020, IRBM.

Does the evidence support the enthusiasm over 3D conformal radiation therapy and dose escalation in the treatment of prostate cancer?

J. Purdy, J. Michalski, 2001, International journal of radiation oncology, biology, physics.

AAPM Task Group 263: Tackling Standardization of Nomenclature for Radiation Therapy

Walter R. Bosch, J. M. Michalski, Todd McNutt, 2015 .

SU-E-P-22: AAPM Task Group 263 Tackling Standardization of Nomenclature for Radiation Therapy

E. Yorke, M. Martel, R. Siochi, 2015 .

2090 Radiation therapy oncology group: 3-D CRT quality assurance guidelines

L. Verhey, T. Phillips, J. Purdy, 1995 .

The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.

James R. Anderson, S. Donaldson, J. Michalski, 2013, International journal of radiation oncology, biology, physics.

Brain tumor committee

W. Yung, M. Prados, G. Barger, 2001 .

RADIATION THERAPY ONCOLOGY GROUP RTOG 98-03 PHASE I/II RADIATION DOSE ESCALATION STUDY APPLYING CONFORMAL RADIATION THERAPY IN SUPRATENTORIAL GLIOBLASTOMA MULTIFORME

J. Michalski, 2003 .

Updated analysis of the phase III, double-blind, randomized, multinational study of radium-223 chloride in castration-resistant prostate cancer (CRPC) patients with bone metastases (ALSYMPCA).

D. Amadori, S. Fosså, A. Haese*, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential dosing of prostate and seminal vesicles using dynamic multileaf collimation.

D. Low, J. Purdy, J. Michalski, 2000, International journal of radiation oncology, biology, physics.

Standardizing Nomenclatures in Radiation Oncology

Andre Dekker, Todd McNutt, Jeff M. Michalski, 2018 .

Simulation in the Determination and Definition of Treatment Volume and Treatment Planning

S. Mutic, J. Purdy, J. Michalski, 2011 .

Impact of Protocol Complexity on Digital Data Integrity Quality Assurance for Clinical Trials Requiring Digital Data Submission

J. Purdy, W. Bosch, J. Matthews, 2008 .

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415

H. Sandler, E. Horwitz, F. Feng, 2021, PloS one.

1011 : A Review of the Activities of the ITC in Support of RTOG Advanced Technology Clinical Trials

W. Curran, J. Purdy, W. Bosch, 2006 .

Remote Global Radiation Oncology Education and Training: A Pathway to Increase Access to High-Quality Radiation Therapy Services in Low- and Middle-Income Countries

J. Michalski, H. Gay, F. Ssewamala, 2023, Advances in Radiation Oncology.

Taking Guatemala From Cobalt to IMRT: A Tale of US Agency Collaboration With Academic Institutions and Industry.

Geoffrey D. Hugo, S. Mutic, J. Michalski, 2020, International journal of radiation oncology, biology, physics.

NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.

Geoffrey E. Wile, A. Kibel, S. Boorjian, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Geoffrey E. Wile, S. Boorjian, N. Agarwal, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

A multi-institutional analysis of adjuvant and salvage radiotherapy after radical prostatectomy

D. Kuban, M. Zelefsky, C. Catton, 2004 .

Ifosfamide and Etoposide Are Superior to Vincristine and Melphalan for Pediatric Metastatic Rhabdomyosarcoma When Administered With Irradiation and Combination Chemotherapy: A Report From the Intergroup Rhabdomyosarcoma Study Group

P. Sorensen, James R. Anderson, T. Triche, 2001, Journal of pediatric hematology/oncology.

Multi-institutional clinical trials: 3-D conformal radiotherapy quality assurance. Guidelines in an NCI/RTOG study evaluating dose escalation in prostate cancer radiotherapy.

J. Purdy, J. Michalski, J. Cox, 1996, Frontiers of radiation therapy and oncology.

The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols

P. Sorensen, James R. Anderson, T. Triche, 2001, Sarcoma.

Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience

J. Michalski, B. V. Van Tine, J. Olsen, 2017, Radiation Oncology.

Estimation of α/β for late rectal toxicity based on RTOG 94-06.

R. Mohan, J. Purdy, W. Bosch, 2011, International journal of radiation oncology, biology, physics.

A multi-institutional analysis of adjuvant and salvage radiotherapy after radical prostatectomy

D. Kuban, M. Zelefsky, C. Catton, 2004 .

Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.

C. Ménard, A. Zietman, C. Catton, 2010, International journal of radiation oncology, biology, physics.

The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.

D. Kuban, M. Zelefsky, A. Zietman, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

D. Kuban, M. Kattan, C. Roehrborn, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of erectile function following treatment for prostate cancer.

John T. Wei, M. Cooperberg, P. Carroll, 2011, JAMA.

Five-year patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer.

I. Kaplan, H. Sandler, E. Horwitz, 2022, International journal of radiation oncology, biology, physics.

Basal cell and squamous cell skin cancers.

A. Oseroff, N. Lee, J. Grichnik, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.

D. Kuban, C. Roehrborn, P. Scardino, 2008, Urology.

Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.

J. Blasko, P. Grimm, K. Wallner, 2005, Brachytherapy.

F. Ullrich, S. Donaldson, J. Michalski, 2008, Pediatric blood & cancer.

A method to evaluate the impact of daily treatment variation on 3-d dimensional dose distributions

J. Purdy, W. Bosch, J. Michalski, 1993 .

Genomic classifier performance in intermediate-risk prostate cancer: Results from NRG Oncology/RTOG 0126 randomized phase III trial.

H. Sandler, P. Tran, É. Vigneault, 2023, International journal of radiation oncology, biology, physics.

J. Michalski, C. Sundaram, J. S. Krumholtz, 2000, Journal of endourology.

Penile cancer: Clinical Practice Guidelines in Oncology.

Geoffrey E. Wile, J. Richie, D. Kuban, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

H. Sandler, M. Regan, M. Sanda, 2014, Cancer.

Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system

Sasa Mutic, Hiram Gay, Michael Roach, 2017, Advances in radiation oncology.